CervoMed Inc. (NASDAQ: CRVO)
$2.3200
+0.0900 ( +5.46% ) 135.6K
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Market Data
Open
$2.3200
Previous close
$2.2300
Volume
135.6K
Market cap
$19.20M
Day range
$2.1810 - $2.3470
52 week range
$1.8000 - $26.3789
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Feb 02, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
8-k | 8K-related | 15 | Jan 05, 2024 |
8-k | 8K-related | 13 | Jan 04, 2024 |
8-k | 8K-related | 13 | Dec 21, 2023 |